Clinical Trials Logo

Monkeypox Virus Infection clinical trials

View clinical trials related to Monkeypox Virus Infection.

Filter by:
  • None
  • Page 1

NCT ID: NCT05058898 Active, not recruiting - Clinical trials for Monkeypox Virus Infection

A One Health Study of Monkeypox Human Infection

AFRIPOX
Start date: September 9, 2021
Phase:
Study type: Observational

This multidisciplinary project aim to understand the epidemiology of the monkeypox in Central African Republic through the identification of the animal reservoir, the clinical and epidemiological description of the human outbreak, through an ethnological approach around risk factors of the disease and through an ecological approach of the ecological context of emergence, and the improvement of biological diagnosis.

NCT ID: NCT02977715 Active, not recruiting - Clinical trials for Monkeypox Virus Infection

JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo

Start date: February 23, 2017
Phase: Phase 3
Study type: Interventional

Mpox is a febrile rash illness caused by the monkeypox virus. Its natural occurrence in the DRC puts healthcare and frontline workers at high risk of acquiring monkeypox virus infections that can prevent them from performing work duties, compromise the overall healthcare delivery in an already fragile system, and can result in death (case fatality estimates are approximately 10%). This is an open-label prospective cohort study in up to 1,600 eligible healthcare workers at risk of mpox infection through their daily work. The study will document mpox exposure and infection in participants while concurrently evaluating the immunogenicity and safety of the vaccine, JYNNEOS (also known as MVA-BN, IMVAMUNE®, IMVANEX), in healthcare personnel in the DRC. Participation in the study is voluntary and open to male and female healthcare personnel ages 18 years and older in Tshuapa Province in The Democratic Republic of Congo who are at risk of monkeypox virus infection through their daily work or laboratory personnel performing diagnostic testing for monkeypox virus.